Completed
A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease
NCT03765762
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Cognitive Clinical Trials Gilbert, Arizona, United States
- Cognitive Clinical Trials Mesa, Arizona, United States
- Cognitive Clinical Trials Phoenix, Arizona, United States
- Pacific Research Network San Diego, California, United States